Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients ...

Lyell Immunopharma shares were 21% higher, at $12.57, after the company entered into a securities purchase agreement for a private placement with institutional and other accredited investors, for ...

Offerpad Solutions (NYSE:OPAD) has entered into a securities purchase agreement with a single institutional investor for the ...

Private placement life insurance can reduce the hardship they create for heirs. Although the Senate Finance has recently ...

The combined company will operate under the name 'ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol ...

Hemostemix ( ($TSE:HEM) ) has provided an update. Hemostemix Inc. has successfully closed a non-brokered private placement, raising $2,969,600 ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, ...

Newlox Gold Ventures (NWLXF) plans to raise up to $2 million, through a non-brokered private placement, offering up to 28,571,429 units at $0.07 each. Each unit shall consist of one common share and ...

Private placement occurs when a company makes an offering of securities to an individual or a small group of investors. Since such an offering does not qualify as a public sale of securities, ...

Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

Although the majority of private offerings operate legally, others do not. Recently, the SEC closed down Castleberry Financial Services Group after it raised $3.8 million through fraud and chicanery.